OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

From Using Claude Code to Growing It — The Complete Environment-Building Series

Related Posts